Physician

Vinay Ashok Shah, MD

According to 2025 Medicare claims, Vinay Shah, MD (NPI: 1013951409) practices ophthalmology in the Oklahoma City, OK market, with the plurality of this provider's patient population coming from Oklahoma, OK. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF OKLAHOMA PLLC (NPI: 1215245014; TIN: 273328222) and primary practice location at 73159-7042.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,233 traditional Medicare patients, billed 51,874 HCPCS/CPT codes, and received $2,695,655 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 592 prescription claims across 224 beneficiaries totaling $25,456 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 15 records totaling $557. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,052,012 to $2,695,655. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $1,052,012 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,208,063 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,304,012 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,465,321 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,603,050 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,526,498 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,481,039 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,437,979 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,746,105 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,695,655 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1198,690$1,052,012
20161,2749,154$1,208,063
20171,3799,429$1,304,012
20181,4989,596$1,465,321
20191,57610,709$1,603,050
20201,4559,729$1,526,498
20211,4249,744$1,481,039
20221,56010,873$1,437,979
20231,43416,209$1,746,105
20241,23351,874$2,695,655

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$19K$39K2015 Drug cost: $25,586 (USD; Tot_Drug_Cst)2016 Drug cost: $30,431 (USD; Tot_Drug_Cst)2017 Drug cost: $33,354 (USD; Tot_Drug_Cst)2018 Drug cost: $36,794 (USD; Tot_Drug_Cst)2019 Drug cost: $34,354 (USD; Tot_Drug_Cst)2020 Drug cost: $34,442 (USD; Tot_Drug_Cst)2021 Drug cost: $38,843 (USD; Tot_Drug_Cst)2022 Drug cost: $35,128 (USD; Tot_Drug_Cst)2023 Drug cost: $26,378 (USD; Tot_Drug_Cst)2024 Drug cost: $25,456 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015159399$25,586
2016187476$30,431
2017204521$33,354
2018209531$36,794
2019221562$34,354
2020209517$34,442
2021242603$38,843
2022219587$35,128
2023168420$26,378
2024224592$25,456

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system7301,225$87
67028Injection of drug into eye4971,895$83
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more363384$56
J9035Injection, bevacizumab, 10 mg222743$55
92134Imaging of retina1,1322,666$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1284,575$6,907
Alphagan PBrimonidine Tartrate13616$3,931
Brimonidine TartrateBrimonidine Tartrate402,135$3,519
OfloxacinOfloxacin1192,801$2,096
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat683,922$1,171

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$557Dutch Ophthalmic, USA
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vinay Ashok Shah, MD?

Tedicare shows public-source Medicare data for Vinay Ashok Shah, MD (NPI 1013951409), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vinay Ashok Shah, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vinay Ashok Shah, MD?

Vinay Ashok Shah, MD is linked to RETINA CONSULTANTS OF OKLAHOMA PLLC (billing NPI 1215245014) in the available physician profile data.

Does Vinay Ashok Shah, MD have Open Payments data?

Vinay Ashok Shah, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.